95 reports

  • 6.1 INTRODUCTION
  • FUNCTIONAL FOOD INGREDIENTS MARKET SIZE, BY TYPE, 2016-2023 (USD MILLION)

PREBIOTICS RESIST GASTRIC ACIDITY AND HYDROLYSIS CAUSED BY ENZYMES AND GASTROINTESTINAL ABSORPTION.

  • Mineral Supplement
  • United States
  • Market Size
  • Arla Foods
  • Cargill Inc.

One of the major reasons for the high bioavailability of organic minerals is that, unlike inorganic minerals, these do not interact with fiber, tannin, phytate, silicates, oxalate, or other minerals in the gastrointestinal tract.

  • Mineral Supplement
  • Pig
  • World
  • Alltech Inc.
  • Kemin Industries, Inc.

THE MICROPEARLS SPRAY FREEZING TECHNOLOGY ALLOWS FOR THE TIMELY RELEASE OF THESE ## KEY NUTRIENTS THROUGHOUT AN ANIMAL' S GASTROINTESTINAL TRACT.

  • Mineral Supplement
  • North America
  • United States
  • World
  • Market Size
  • VITAMIN & MINERAL PREMIXES MARKET, BY FUNCTIONALITY

Q. ##.

  • Mineral Supplement
  • World
  • Market Size
  • Glanbia plc
  • Nutreco N.V.

MARKET ##.

  • Mineral Supplement
  • APAC
  • Japan
  • World
  • Demand
  • CLASSIFICATION OF DIABETIC NEUROPATHIES

IT ENROLLED ## PATIENTS, SPLIT INTO SEVEN ARMS, RECEIVING MIROGABALIN ##MG/ DAY, ##MG/ DAY, ##MG/ DAY, ##MG/ DAY, ##MG/ DAY, PREGABALIN ##MG/ DAY, OR PLACEBO, SPLIT IN A ##:##:##:##:##:##:## RATIO.

  • Type 2 Diabetes
  • Forecast
  • Daiichi Sankyo Company
  • Depomed, Inc.
  • Pfizer Inc.

You can easily book an appointment with one online.

  • Mineral Supplement
  • World
  • Market Size
  • Alltech Inc.
  • Kemin Industries, Inc.

GLP-## IS AN INCRETIN HORMONE THAT IS RELEASED FROM CELLS IN THE GASTROINTESTINAL TRACT INTO THE CIRCULATION IN RESPONSE TO INGESTED NUTRIENTS FROM FOOD.

  • Mineral Supplement
  • Type 2 Diabetes
  • Southeast Asia
  • Novo Nordisk Group
  • Sanofi S.A.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Mineral Supplement
  • China
  • Demand
  • Amway Corporation
  • Joincare Pharmaceutical Group Industry Co., Ltd.
  • 7.1 OVERVIEW

DESPITE ITS LOW COST, GASTROINTESTINAL (GI) SIDE EFFECTS ARE VERY COMMON WITH ACARBOSE, WHICH HAS PREVENTED ITS WIDESPREAD USE.

  • Type 2 Diabetes
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

Seminars in Diabetologica; ##(##): ##-##.

  • Type 2 Diabetes
  • Allergan plc
  • Clearside Biomedical, Inc.
  • Novartis AG
  • Regeneron Pharmaceuticals, Inc.
  • ASTRAZENECA

These agents are associated with reduced rates of hypoglycemia, moderate and continuous weight loss, and gastrointestinal side effects such as nausea and vomiting.

  • Type 2 Diabetes
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Energy
  • Mineral Supplement
  • Vitamin
  • China
  • Demand

It is estimated that worldwide one in five men and one in three women are at risk of an osteoporotic fracture.

  • Mineral Supplement
  • World
  • Forecast
  • Quidel Corporation
  • Roche Group

LIST OF COMPANIES AND ORGANIZATIONS ##.

  • Type 2 Diabetes
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Resverlogix Corp.
  • Vifor Pharma

The subsidiary is focused on aging care, critical care & surgery, gastrointestinal function, and pediatrics.

  • Mineral Supplement
  • North America
  • United States
  • Demand
  • Market Size

Gastrointestinal complications of diabetes.

  • Type 2 Diabetes
  • East Asia
  • North America
  • Northern Europe
  • Scandinavia

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES; ##(##): ##-##.

  • Mineral Supplement
  • Type 2 Diabetes
  • United States
  • Conatus Pharmaceuticals Inc.
  • Gilead Sciences, Inc.

Q. ##.

  • Mineral Supplement
  • United States
  • Cargill Inc.
  • Koninklijke DSM N.V.
  • Nutreco N.V.

THE ENDOBARRIER GASTROINTESTINAL LINER IS TRANSORALLY PLACED IN THE GASTROINTESTINAL TRACT IN ORDER TO BYPASS A PORTION OF THE INTESTINE.

  • Type 2 Diabetes
  • United States
  • EnteroMedics Inc.
  • Novo Nordisk Group
  • VIVUS, Inc.

PATIENTS IN THE STANDARD CARE GROUP DEVELOPED CELLULITIS OF THE EFFECTED EXTREMITY (TWO PATIENTS), A GASTROINTESTINAL BLEED (ONE PATIENT), AND ACUTE PYELONEPHRITIS (ONE PATIENT).

  • Type 2 Diabetes
  • FirstString Research, Inc.
  • Organogenesis, Inc.
  • Osiris Therapeutics, Inc.
  • Smith & Nephew Plc
  • Trial Results

Hoffmann-La Roche Ltd. ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## Mallinckrodt Plc ## ## ## ## ## ## ## ## Pfizer Inc. ## ## ## ## ## ## ## ## Rigel Pharmaceuticals, Inc. ## ## ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ## ## ## Cumberland Phar

  • Type 2 Diabetes
  • World
  • Anthera Pharmaceuticals, Inc.
  • Astellas Pharma Inc.
  • Novartis AG

References P##(SHC) Therapeutic Area/ Disease Indications Diabetes Gastrointestinal lesions University of Bari Aldo Moro, Italy.

  • Insulin
  • Type 2 Diabetes
  • United States
  • MC2 Biotek Group
  • POXEL SA
  • PIPELINE BY ELI LILLY AND CO, H2 2018
  • PIPELINE BY LONGEVITY BIOTECH INC, H2 2018

The company' s hybridtide scaffold provides durable protease resistance in biological matrices such as gastrointestinal tract and bloodstream.

  • Mineral Supplement
  • Therapy
  • Type 2 Diabetes
  • World
  • Product Initiative

It acts by targeting free fatty acid receptor ## (GPR##).

  • Diabetes
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • GlaxoSmithKline plc
  • Pipeline by Ardelyx Inc, H1 2018

The drug candidate is an agonist of TGR##, a G protein-coupled receptor found in the gastrointestinal (GI) tract.

  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • World
  • Product Initiative
  • Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Product Development Milestones
  • NOV 04, 2010: ARENA PHARMACEUTICALS PROVIDES UPDATE ON GPR119 PORTFOLIO FOR TYPE 2 DIABETES

GPR## is expressed at high concentrations in the pancreas and gastrointestinal tract.

  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • World
  • Product Initiative
  • Type 2 Diabetes Mellitus, Global, Pipeline Size by
  • Type 2 Diabetes Mellitus, Global, Key Features of Neuromedin U Receptor 1 (NMUR1), 2018

It can cause significant gastrointestinal and genitourinary problems, and in some cases can lead to erectile dysfunction.

  • Diabetes
  • Insulin
  • Type 2 Diabetes
  • World
  • Deals & Alliance
  • RDX-98940 - DRUG PROFILE
  • SMALL MOLECULES TO AGONIZE GLP1 AND GIP RECEPTORS FOR NON ALCOHOLIC STEATOHEPATITIS, OBESITY AND TYPE 2 DIABETES - DRUG PROFILE

IN APRIL ##, 2016, EISAI' S GASTROINTESTINAL DISEASE BUSINESS AND AJINOMOTO PHARMACEUTICALS, WITH AMINO ACIDS AT ITS CORE, WILL BE INTEGRATED AND COMMENCE BUSINESS AS EA PHARMA.

  • Mineral Supplement
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative
  • PIPELINE BY ELI LILLY AND CO, H1 2018

The drug candidate acts by targeting glucagon like peptide ## (GLP-##) and gastric inhibitory polypeptide (GIP).

  • Mineral Supplement
  • Type 2 Diabetes
  • United States
  • World
  • Product Initiative